Thomas H Taylor
Overview
Explore the profile of Thomas H Taylor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
22.
Suda K, Hicks L, Roberts R, Hunkler R, Taylor T
Antimicrob Agents Chemother
. 2014 Mar;
58(5):2763-6.
PMID: 24590486
Antibiotic-resistant bacteria are an increasing threat to the effectiveness of antibiotics. The majority of antibiotics are prescribed in primary care settings for upper respiratory tract infections. The purpose of this...
23.
ODell J, Mikuls T, Taylor T, Ahluwalia V, Brophy M, Warren S, et al.
N Engl J Med
. 2013 Jun;
369(4):307-18.
PMID: 23755969
Background: Few blinded trials have compared conventional therapy consisting of a combination of disease-modifying antirheumatic drugs with biologic agents in patients with rheumatoid arthritis who have active disease despite treatment...
24.
Armstrong W, Taylor T, Kennedy A, Melrose R, Messadi D, Gu M, et al.
Cancer Prev Res (Phila)
. 2013 May;
6(5):410-8.
PMID: 23639862
Oral premalignancy serves as an ideal model for study of chemopreventive agents. Although 13-cis-retinoic acid showed reversal of oral premalignancy, toxicity, and reversal of clinical response after cessation of therapy...
25.
Taylor T, Mecchella J, Larson R, Kerin K, MacKenzie T
Am J Med
. 2012 Oct;
125(11):1126-1134.e7.
PMID: 23098865
Objective: Streamlining the initiation of allopurinol could result in a cost benefit for a common medical problem and obviate the perception that no treatment is required once acute attacks have...
26.
Liu F, Bessonova L, Taylor T, Ziogas A, Meyskens Jr F, Anton-Culver H
Pigment Cell Melanoma Res
. 2012 Oct;
26(1):128-35.
PMID: 23095171
Using US SEER17 Registry data, age-specific melanoma incidence rates were calculated and comparisons were made between males and females. Relative Risk (RR) for males and females in each age group...
27.
Angra P, Taylor T, Iademarco M, Metchock B, Rex Astles J, Ridderhof J
J Clin Microbiol
. 2012 Feb;
50(4):1233-9.
PMID: 22301024
We present a statistical summary of results from the Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis Drug Susceptibility Testing, 1994 to 2008, implemented by the U.S. Centers for Disease...
28.
Raj K, Taylor T, Wray C, Stamos M, Zell J
J Carcinog
. 2011 Apr;
10:6.
PMID: 21483654
Background: Patients with history of colorectal cancer (CRC) are at increased risk for developing a second primary colorectal cancer (SPCRC) as compared to the general population. However, the degree of...
29.
Bessonova L, Taylor T, Mehta R, Zell J, Anton-Culver H
Cancer Epidemiol Biomarkers Prev
. 2011 Jan;
20(2):389-96.
PMID: 21217087
Objectives: Hormone-receptor (HR) and HER2/neu-receptor (HER2) status of breast tumors are important indicators for targeted therapies. We examine the association of receptor status and risk for a second breast cancer....
30.
Katz M, Taylor T, Al-Refaie W, Hanna M, Imagawa D, Anton-Culver H, et al.
J Gastrointest Surg
. 2010 Nov;
15(1):165-74.
PMID: 21082275
Background: Pancreatic adenosquamous carcinoma has historically been characterized as having a more aggressive clinical course than ductal adenocarcinoma. The natural history of this disease, however, is essentially unknown. Methods: We...